COMPUGEN LTD./ IL0010852080 /
5/3/2024 8:06:56 AM | Chg. +0.164 | Volume | Bid8:54:11 PM | Ask8:54:11 PM | High | Low |
---|---|---|---|---|---|---|
1.984EUR | +9.01% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 1.984 | 1.984 |
GlobeNewswire
3/8/2022
XOMA Reports Full Year 2021 Financial Results and Highlights Recent Operational Events
GlobeNewswire
11/4/2021
XOMA Reports Third Quarter 2021 Financial Results and Highlights Recent Operational Events
GlobeNewswire
5/6/2021
XOMA Reports First Quarter 2021 Financial Results and Highlights Recent Operational Events
GlobeNewswire
3/11/2021
Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D.
GlobeNewswire
1/20/2021
Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors
GlobeNewswire
5/5/2020
XOMA Reports First Quarter 2020 Financial Results and Provides COVID-19 Business Update
GlobeNewswire
3/10/2020
XOMA Reports Fourth Quarter and Full-Year 2019 Financial Results and Operating Highlights
GlobeNewswire
12/12/2019
Janpix, Inc. Announces Appointment of Sanford (Sandy) Zweifach as Executive Chairman to its Board of...
GlobeNewswire
10/22/2019
Global Predisposition Biomarkers Market by Application, End-user & Region - Forecast to 2024
GlobeNewswire
4/12/2019
Report: Exploring Fundamental Drivers Behind Masco, Ascena Retail Group, Minerva Neurosciences, Comp...
GlobeNewswire
1/30/2019
Kamada Appoints Senior Biopharmaceutical Executive Michal Ayalon, Ph.D., as Vice President of Resear...
GlobeNewswire
12/17/2018
Chronic Respiratory Disease Drug Development Pipeline Review, 2018: Therapeutics Under Development a...
GlobeNewswire
5/3/2018
Outsourcing in Drug Discovery 2017-2018 & 2022 - Focus on the Contract Research Organization (CRO) M...
GlobeNewswire
11/16/2017
Antibody Drug Conjugates Market, 2030 - Market is Anticipated to Grow at a CAGR to 19.4%
GlobeNewswire
6/14/2007
DeveloGen and Andromeda, a newly formed wholly-owned subsidiary of Clal Biotechnology Industries, Co...
GlobeNewswire
4/17/2007
DeveloGen and Andromeda, a newly formed wholly-owned subsidiary of Clal Biotechnology Industries, Si...
GlobeNewswire
11/17/2003
LORANTIS RECEIVES £25 ($42) MILLION IN NEW FINANCING LED BY APAX
PARTNERS FUNDS